APA (7th ed.) Citation

M, C., S, P., R, P., K, P., J, G., T, A., & S, H. (2025). Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: Mechanisms, clinical implications, and therapeutic potential. Journal of Crohn's & colitis, 19(9), . https://doi.org/10.1093/ecco-jcc/jjaf167

Chicago Style (17th ed.) Citation

M, Colwill, Povlsen S, Pollok R, Patel K, Goodhand J, Ahmad T, and Honap S. "Glucagon-like Peptide-1 (GLP-1) Receptor Agonists in Inflammatory Bowel Disease: Mechanisms, Clinical Implications, and Therapeutic Potential." Journal of Crohn's & Colitis 19, no. 9 (2025). https://doi.org/10.1093/ecco-jcc/jjaf167.

MLA (9th ed.) Citation

M, Colwill, et al. "Glucagon-like Peptide-1 (GLP-1) Receptor Agonists in Inflammatory Bowel Disease: Mechanisms, Clinical Implications, and Therapeutic Potential." Journal of Crohn's & Colitis, vol. 19, no. 9, 2025, https://doi.org/10.1093/ecco-jcc/jjaf167.